Author

E. Strauss

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2 Ecology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:multiple species· 1 Organism:plant (other)· 1

Frequent Co-Authors

A. A. Lauber· 1 shared A. B. Frost· 1 shared A. Ciulli· 1 shared A. E. Sexton· 1 shared A. G. Maier· 1 shared A. Gollner· 1 shared A. Hoegl· 1 shared A. L. Sewell· 1 shared

Activity by Year

2017-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. A. Lauber

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Targeting cancer with small molecule pan-KRAS degraders

J. Popow, W. Farnaby, A. Gollner, C. Kofink, G. Fischer, M. Wurm, D. Zollman, A. Wijaya, N. Mischerikow, C. Hasenoehrl, P. Prokofeva, H. Arnhof, S. Arce-Solano, S. Bell, G. Boeck, , A. Ciulli

A single small molecule degrader targets 13 out of 17 prevalent oncogenic KRAS alleles, inhibiting growth of KRAS-driven cancer cell lines and inducing tumour regression in vivo.

bioRxiv · Oct 24, 2023Pharmacology & Toxicology

High syphilis seropositivity in European brown hares, Lower Saxony, Germany

L. Hisgen, L. Abel, L. K. Hallmaier-Wacker, S. Lueert, U. Siebert, M. Faehndrich, E. Strauss, U. Voigt, M. Novakova, D. Smajs, S. Knauf

The paper reports high seropositivity for Treponema paraluisleporidarum in European brown hares in Lower Saxony, Germany.

bioRxiv · Jan 5, 2020Ecology

Mutations in the pantothenate kinase of Plasmodium falciparum confer diverse sensitivity profiles to antiplasmodial pantothenate analogues

E. T. Tjhin, C. Spry, A. L. Sewell, A. Hoegl, L. Barnard, A. E. Sexton, V. M. Howieson, A. G. Maier, D. J. Creek, E. Strauss, R. Marquez, K. Auclair, K. J. Saliba

The paper identifies mutations in Plasmodium falciparum pantothenate kinase genes that confer resistance to pantothenate analogues and reveal different mechanisms of action for these compounds.

bioRxiv · Jul 24, 2017Pharmacology & Toxicology